TNDM - Tandem Diabetes Care Inc

TNDM - Tandem Diabetes Care Inc

https://www.tandemdiabetes.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. ( NASDAQ: TNDM ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Tandem Diabetes Care ( NASDAQ:TNDM )

Benzinga • 2 days, 17 hours ago • score: -0.06

NEW YORK, Sept. 12, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc.

Jim Cramer: This Is The Right Time To Buy This Energy Stock - Cintas ( NASDAQ:CTAS ) , Intuitive Surgical ( NASDAQ:ISRG )

Benzinga • 4 days, 4 hours ago • score: 0.46

Cramer is not going to pull the trigger on Intuitive Surgical. Tandem Diabetes Care is a "speculative stock for younger people I actually encourage," says Cramer. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On

TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up

Zacks Commentary • 1 month ago • score: 0.02

Tandem Diabetes posts record Q2 sales and higher margins, but earnings miss sends shares tumbling 20%.

Tandem Diabetes Care, Inc. ( TNDM ) Reports Q2 Loss, Beats Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.14

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Bears are Losing Control Over Tandem Diabetes Care ( TNDM ) , Here's Why It's a 'Buy' Now

Zacks Commentary • 1 month, 1 week ago • score: 0.39

Tandem Diabetes Care (TNDM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.

52W High

$47.60

52W Low

$9.98

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.46

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

1111.11

EV/EBITDA (<8 favorable)

-10.72

EV/Revenue (<3 favorable)

0.98

P/S (TTM) (<3 favorable)

0.85

P/B (<3 favorable)

6.38

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.97%

Institutions (25–75% balanced)

120.71%

Shares Outstanding

67,570,000

Float

61,826,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,001,719,000

Gross Profit (TTM)

526,370,000

EPS (TTM)

-3.08

Profit Margin (>10% good)

-0.21%

Operating Margin (TTM) (higher better)

-0.13%

ROE (TTM) (>15% strong)

-1.12%

EPS YoY (Quarterly) (>10% good)

-0.37

Revenue YoY (Quarterly) (>8% good)

0.09

Momentum

Bearish momentum

Value

-0.2580

Previous

-0.2600

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025